You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 10, October 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Controversies in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Alert me on articles by topic

Multiple Sclerosis Is Not an Autoimmune Disease

Abhijit Chaudhuri, DM, MD, PhD, FACP, FRCP; Peter O. Behan, DSc, MD, FRCP, FACP

Arch Neurol. 2004;61:1610-1612.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Disease is very old and nothing about it has changed. It is we who change as we learn to recognize what was formerly imperceptible.—J. M. Charcot

The cause of multiple sclerosis (MS) and its pathogenesis are unknown, but 2 main theories have emerged: a viral cause and an autoimmune cause. In the past half century, however, research and therapy have been driven by the autoimmune hypothesis. We propose that MS is not an autoimmune disease but a genetically determined disorder characterized by metabolically dependent neurodegeneration.

AUTOIMMUNITY AND MS

The idea that MS may be a central nervous system, myelin-specific autoimmune disease is based on 2 sets of observations. The first is that fatal cases of acute disseminated encephalomyelitis (ADEM) have sleevelike, perivenous myelin damage up to 2 mm in diameter, in association with cellular infiltrates. The second observation is that . . . [Full Text of this Article]


MS THERAPY BASED ON AUTOIMMUNITY

MS IS A METABOLICALLY DEPENDENT, NEURODEGENERATIVE DISEASE

CONCLUSIONS

NOTE ADDED DURING FINAL SUBMISSION

AUTHOR INFORMATION
Author Affiliations: Division of Clinical Neurology, University of Glasgow, Scotland.


RELATED ARTICLES

Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease
Howard L. Weiner
Arch Neurol. 2004;61(10):1613-1615.
EXTRACT | FULL TEXT  

Is Multiple Sclerosis an Autoimmune Disorder?
E. S. Roach
Arch Neurol. 2004;61(10):1615-1616.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rituximab in relapsing-remitting multiple sclerosis.
Schrijver et al.
NEJM 2008;358:2645-2645.
FULL TEXT  

Demyelinating diseases.
Love
J. Clin. Pathol. 2006;59:1151-1159.
ABSTRACT | FULL TEXT  

Multiple sclerosis: looking beyond autoimmunity
Chaudhuri and Behan
JRSM 2005;98:303-306.
FULL TEXT  

Treatment of multiple sclerosis: beyond the NICE guidelines
Chaudhuri and Behan
QJM 2005;98:373-378.
ABSTRACT | FULL TEXT  

Evaluating the Evidence for Multiple Sclerosis as an Autoimmune Disease
Altmann
Arch Neurol 2005;62:688-688.
FULL TEXT  

Evaluating the Evidence for Multiple Sclerosis as an Autoimmune Disease--Reply
Chaudhuri and Behan
Arch Neurol 2005;62:688-689.
FULL TEXT  

Is Multiple Sclerosis an Autoimmune Disorder?
Roach
Arch Neurol 2004;61:1615-1616.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.